J. Kaitlin Morrison - Concepedia

Author

J. Kaitlin Morrison

University of North Carolina at Chapel Hill

Also Known As

Dittus, C., J Kaitlin Morrison, J. Kaitlin Morrison, J. Kaitlin C Morrison, J. Kaitlin Morrison, Jamieson, Katarzyna J, Julia Kaitlin Morrison, Julia Morrison

Publications

548

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill UNC Lineberger Comprehensive Cancer Center East Carolina University Levine Cancer Institute Lincoln Memorial University

About

J. Kaitlin Morrison is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	92
2	Cellular Therapies	2	2	33
3	Health Sciences	1	1	21
4	Natural Sciences	1	1	14
5	Cell Biology	1	1	14

J. Kaitlin Morrison

Publications

501

Citations

H-Index

Page 1

	Year	Citations
Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma Jia Ruan, Peter Martin, Richard R. Furman, Journal of Clinical Oncology	2010	317
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma Timothy Voorhees, Beibo Zhao, Jorge D. Oldan, Blood Advances Lymphoid NeoplasiaRadiation OncologyHodgkin LymphomaCancer ImmunosurveillanceCd30.car-t Cell Infusion	2021	45
CD30-Directed CAR-T Cells Co-Expressing CCR4 in Relapsed/Refractory Hodgkin Lymphoma and CD30+ Cutaneous T Cell Lymphoma Natalie S. Grover, Anastasia Ivanova, Dominic T. Moore, Blood	2021	31
Cap-Independent Translation Promotes C. elegans Germ Cell Apoptosis through Apaf-1/CED-4 in a Caspase-Dependent Mechanism Vince Contreras, Andrew J. Friday, J. Kaitlin Morrison, PLoS ONE	2011	21
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study Natalie S. Grover, George Hucks, Marcie Riches, The Lancet Haematology Lymphoid NeoplasiaCell TherapyTransplantationHigh-risk Cd30+ LymphomaMedicine	2024	21
Spatial and temporal translational control of germ cell mRNAs mediated by the eIF4E isoform IFE-1 Andrew J. Friday, Melissa A. Henderson, J. Kaitlin Morrison, Journal of Cell Science	2015	16
Induction of cap-independent BiP (<i>hsp-3</i>) and Bcl-2 (<i>ced-9</i>) translation in response to eIF4G (IFG-1) depletion in<i>C. elegans</i> J. Kaitlin Morrison, Andrew J. Friday, Melissa A. Henderson, Translation Molecular RegulationGeneticsApoptosisMolecular BiologyCell Death	2014	14
A Phase Ib/II Study of Anti-CD30 Chimeric Antigen Receptor T Cells for Relapsed/Refractory CD30+ Lymphomas Natalie S. Grover, Steven I. Park, Anastasia Ivanova, Biology of Blood and Marrow Transplantation	2019	13
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas Nicholas Tschernia, Hillary Heiling, Allison M. Deal, Journal for ImmunoTherapy of Cancer Chimeric Antigen ReceptorLymphoid NeoplasiaCell TherapyCancer ImmunosurveillanceAutoimmune Disease	2023	12
Clinical Responses to CAR.CD30-T Cells in Patients with CD30+ Lymphomas Relapsed after Multiple Treatments Including Brentuximab Vedotin Natalie S. Grover, Steven Park, Anastasia Ivanova, Blood	2018	11

Page 1